210 related articles for article (PubMed ID: 38278978)
1. Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20.
Fatima I; Ahmad R; Barman S; Gowrikumar S; Pravoverov K; Primeaux M; Fisher KW; Singh AB; Dhawan P
Br J Cancer; 2024 Apr; 130(6):1046-1058. PubMed ID: 38278978
[TBL] [Abstract][Full Text] [Related]
2. The E3 ubiquitin ligase NEDD4 regulates chemoresistance to 5-fluorouracil in colorectal cancer cells by altering JNK signalling.
Anand S; Nedeva C; Chitti SV; Fonseka P; Kang T; Gangoda L; Tabassum NI; Abdirahman S; Arumugam TV; Putoczki TL; Kumar S; Mathivanan S
Cell Death Dis; 2023 Dec; 14(12):828. PubMed ID: 38097550
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer.
Lee JH; Lee SW
Mol Biol Rep; 2019 Aug; 46(4):3835-3842. PubMed ID: 31028570
[TBL] [Abstract][Full Text] [Related]
4. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
Hu J; Cai G; Xu Y; Cai S
Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer.
Xi C; Wang L; Yu J; Ye H; Cao L; Gong Z
Biochem Biophys Res Commun; 2018 Sep; 503(4):2286-2292. PubMed ID: 29959920
[TBL] [Abstract][Full Text] [Related]
6. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p.
Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C
Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958
[TBL] [Abstract][Full Text] [Related]
7. The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer.
Zhu X; Li C; Gao Y; Zhang Q; Wang T; Zhou H; Bu F; Chen J; Mao X; He Y; Wu K; Li N; Luo H
J Exp Clin Cancer Res; 2024 Jan; 43(1):7. PubMed ID: 38163859
[TBL] [Abstract][Full Text] [Related]
8. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
Cui Z; Wang Q; Deng MH; Han QL
Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
[TBL] [Abstract][Full Text] [Related]
9. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
[TBL] [Abstract][Full Text] [Related]
10. Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells.
Sakatani A; Sonohara F; Goel A
Carcinogenesis; 2019 May; 40(3):422-431. PubMed ID: 30590435
[TBL] [Abstract][Full Text] [Related]
11. microRNA-143 interferes the EGFR-stimulated glucose metabolism to re-sensitize 5-FU resistant colon cancer cells via targeting hexokinase 2.
Chen W; Chen Y; Hui T
J Chemother; 2023 Oct; 35(6):539-549. PubMed ID: 36546770
[TBL] [Abstract][Full Text] [Related]
12. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance.
Pothuraju R; Rachagani S; Krishn SR; Chaudhary S; Nimmakayala RK; Siddiqui JA; Ganguly K; Lakshmanan I; Cox JL; Mallya K; Kaur S; Batra SK
Mol Cancer; 2020 Feb; 19(1):37. PubMed ID: 32098629
[TBL] [Abstract][Full Text] [Related]
13. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
[TBL] [Abstract][Full Text] [Related]
14. The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study.
Alalikhan A; Ebrahimi S; Aliee A; Mirzavi F; Hashemy SI
Med Oncol; 2024 Feb; 41(3):70. PubMed ID: 38340190
[TBL] [Abstract][Full Text] [Related]
15. Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation.
Zhang L; Zhou R; Zhang W; Yao X; Li W; Xu L; Sun X; Zhao L
J Exp Clin Cancer Res; 2019 Mar; 38(1):120. PubMed ID: 30850009
[TBL] [Abstract][Full Text] [Related]
16. BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers.
Lavitrano M; Ianzano L; Bonomo S; Cialdella A; Cerrito MG; Pisano F; Missaglia C; Giovannoni R; Romano G; McLean CM; Voest EE; D'Amato F; Noli B; Ferri GL; Agostini M; Pucciarelli S; Helin K; Leone BE; Canzonieri V; Grassilli E
J Pathol; 2020 Feb; 250(2):134-147. PubMed ID: 31518438
[TBL] [Abstract][Full Text] [Related]
17. Alarmin IL-33 orchestrates antitumoral T cell responses to enhance sensitivity to 5-fluorouracil in colorectal cancer.
Song M; Yang J; Di M; Hong Y; Pan Q; Du Y; Xiang T; Liu J; Tang Y; Wang Q; Li Y; He J; Chen H; Zhao J; Weng D; Zhang Y; Xia JC
Theranostics; 2023; 13(5):1649-1668. PubMed ID: 37056569
[No Abstract] [Full Text] [Related]
18. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
19. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
[TBL] [Abstract][Full Text] [Related]
20. Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death.
Petersen JSSM; Baird SK
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2945-2953. PubMed ID: 34148157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
